Loading…
TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells
Our recent evidence showed that Toll like receptor 9 (TLR9) signaling could enhance the growth and metastatic potential of human lung cancer cells through repressing microRNA-7 (miR-7) expression. Human antigen R (HuR) has been involved in stabilizing multiple mRNAs in cellular biology. However, whe...
Saved in:
Published in: | Cancer cell international 2013-09, Vol.13 (1), p.90-90, Article 90 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53 |
---|---|
cites | cdi_FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53 |
container_end_page | 90 |
container_issue | 1 |
container_start_page | 90 |
container_title | Cancer cell international |
container_volume | 13 |
creator | Li, Yong-Ju Wang, Chun-Hong Zhou, Ya Liao, Zheng-Yuan Zhu, Shun-Fei Hu, Yan Chen, Chao Luo, Jun-Min Wen, Zhen-Ke Xu, Lin |
description | Our recent evidence showed that Toll like receptor 9 (TLR9) signaling could enhance the growth and metastatic potential of human lung cancer cells through repressing microRNA-7 (miR-7) expression. Human antigen R (HuR) has been involved in stabilizing multiple mRNAs in cellular biology. However, whether HuR also contributed to the altered expression of miR-7 in TLR9 signaling stimulated human lung cancer cells remains to be elucidated.
The expression of HuR in human lung cancer 95D cells treated with TLR9 agonist CpG Oligonucleotides (ODNs) was detected by Real-time PCR and Western blot assay. To explore the possible role of HuR on miR-7 expression, eukaryotic expression vector encoding HuR was transiently transfected into 95D cells and then the expression of miR-7 was detected by Real-time PCR assay. Moreover, RNA interference, western blot, Real-time PCR, MTT assay, BrdU labeling, invasion assay and scratch assay were employed to examine the disrupt effect of HuR on miR-7 expression in human lung cancer cells treated with CpG ODNs. Finally, inhibitors for PI3K, Akt or Erk respectively, and western blot were performed to explore the possible signaling pathway related to HuR expression in CpG ODNs treated human lung cancer cells.
Our data showed that TLR9 agonist CpG ODNs could induce the expression of HuR in human lung cancer cells. Moreover, overexpression of HuR could reduce the expression of miR-7 in lung cancer cells. Notably, down-regulation of HuR using RNA interference restored miR-7 expression in CpG ODNs treated lung cancer cells, accompanied by enhanced growth and metastatic potential. Finally, CpG ODNs could induce HuR expression through Akt pathway.
Our findings indicated that HuR could act as regulator in regulating TLR9 signaling associated biological effect in human lung cancer cells, which might be helpful for the understanding of the potential role of HuR in tumor biology. |
doi_str_mv | 10.1186/1475-2867-13-90 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3847485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3075398281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53</originalsourceid><addsrcrecordid>eNqNkUtr3DAUhUVpaR7tursi6CYbJ3pL3hTK0DxgoDCkayHLskfBllzJCu2_r53HkGZVEOjq6NNB9x4APmF0jrESF5hJXhElZIVpVaM34PigvH1RH4GTnO8QwlIJ9B4cEYYQY4Icg3S73dUw-z6YwYceJjcll7Nr4VzGmGAu04OwlKPfVRK63w9nHwOc9ymWfg_LVCXXl8HMqxo7eF120Ae4L6MJcCiLrTXBugStG4b8AbzrzJDdx6f9FPy8_H67ua62P65uNt-2leWcz5WVrcTKKcNrp9q2JcZQYhh2lDWNoEoiSTrSUGYFwYZ1i-i4MHXXWoabhtNT8PXRdyrN6FrrwpzMoKfkR5P-6Gi8_vcm-L3u472mikmmVoOzJ4MUfxWXZz36vLZggosla8x4jXm9zPE_UKYIwTVaXb-8Qu9iScv4V4rSZQkhFurikbIp5pxcd_g3RnqNXq_h6jVcjamu0fLi88t2D_xz1vQvaG2rCQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1433433666</pqid></control><display><type>article</type><title>TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central Free</source><creator>Li, Yong-Ju ; Wang, Chun-Hong ; Zhou, Ya ; Liao, Zheng-Yuan ; Zhu, Shun-Fei ; Hu, Yan ; Chen, Chao ; Luo, Jun-Min ; Wen, Zhen-Ke ; Xu, Lin</creator><creatorcontrib>Li, Yong-Ju ; Wang, Chun-Hong ; Zhou, Ya ; Liao, Zheng-Yuan ; Zhu, Shun-Fei ; Hu, Yan ; Chen, Chao ; Luo, Jun-Min ; Wen, Zhen-Ke ; Xu, Lin</creatorcontrib><description>Our recent evidence showed that Toll like receptor 9 (TLR9) signaling could enhance the growth and metastatic potential of human lung cancer cells through repressing microRNA-7 (miR-7) expression. Human antigen R (HuR) has been involved in stabilizing multiple mRNAs in cellular biology. However, whether HuR also contributed to the altered expression of miR-7 in TLR9 signaling stimulated human lung cancer cells remains to be elucidated.
The expression of HuR in human lung cancer 95D cells treated with TLR9 agonist CpG Oligonucleotides (ODNs) was detected by Real-time PCR and Western blot assay. To explore the possible role of HuR on miR-7 expression, eukaryotic expression vector encoding HuR was transiently transfected into 95D cells and then the expression of miR-7 was detected by Real-time PCR assay. Moreover, RNA interference, western blot, Real-time PCR, MTT assay, BrdU labeling, invasion assay and scratch assay were employed to examine the disrupt effect of HuR on miR-7 expression in human lung cancer cells treated with CpG ODNs. Finally, inhibitors for PI3K, Akt or Erk respectively, and western blot were performed to explore the possible signaling pathway related to HuR expression in CpG ODNs treated human lung cancer cells.
Our data showed that TLR9 agonist CpG ODNs could induce the expression of HuR in human lung cancer cells. Moreover, overexpression of HuR could reduce the expression of miR-7 in lung cancer cells. Notably, down-regulation of HuR using RNA interference restored miR-7 expression in CpG ODNs treated lung cancer cells, accompanied by enhanced growth and metastatic potential. Finally, CpG ODNs could induce HuR expression through Akt pathway.
Our findings indicated that HuR could act as regulator in regulating TLR9 signaling associated biological effect in human lung cancer cells, which might be helpful for the understanding of the potential role of HuR in tumor biology.</description><identifier>ISSN: 1475-2867</identifier><identifier>EISSN: 1475-2867</identifier><identifier>DOI: 10.1186/1475-2867-13-90</identifier><identifier>PMID: 24004462</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>1-Phosphatidylinositol 3-kinase ; Binding sites ; Gene expression ; Lung cancer ; MicroRNAs ; Primary Research ; Proteins ; Software ; Studies</subject><ispartof>Cancer cell international, 2013-09, Vol.13 (1), p.90-90, Article 90</ispartof><rights>2013 Li et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Li et al.; licensee BioMed Central Ltd. 2013 Li et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53</citedby><cites>FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847485/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1433433666?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24004462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Yong-Ju</creatorcontrib><creatorcontrib>Wang, Chun-Hong</creatorcontrib><creatorcontrib>Zhou, Ya</creatorcontrib><creatorcontrib>Liao, Zheng-Yuan</creatorcontrib><creatorcontrib>Zhu, Shun-Fei</creatorcontrib><creatorcontrib>Hu, Yan</creatorcontrib><creatorcontrib>Chen, Chao</creatorcontrib><creatorcontrib>Luo, Jun-Min</creatorcontrib><creatorcontrib>Wen, Zhen-Ke</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><title>TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells</title><title>Cancer cell international</title><addtitle>Cancer Cell Int</addtitle><description>Our recent evidence showed that Toll like receptor 9 (TLR9) signaling could enhance the growth and metastatic potential of human lung cancer cells through repressing microRNA-7 (miR-7) expression. Human antigen R (HuR) has been involved in stabilizing multiple mRNAs in cellular biology. However, whether HuR also contributed to the altered expression of miR-7 in TLR9 signaling stimulated human lung cancer cells remains to be elucidated.
The expression of HuR in human lung cancer 95D cells treated with TLR9 agonist CpG Oligonucleotides (ODNs) was detected by Real-time PCR and Western blot assay. To explore the possible role of HuR on miR-7 expression, eukaryotic expression vector encoding HuR was transiently transfected into 95D cells and then the expression of miR-7 was detected by Real-time PCR assay. Moreover, RNA interference, western blot, Real-time PCR, MTT assay, BrdU labeling, invasion assay and scratch assay were employed to examine the disrupt effect of HuR on miR-7 expression in human lung cancer cells treated with CpG ODNs. Finally, inhibitors for PI3K, Akt or Erk respectively, and western blot were performed to explore the possible signaling pathway related to HuR expression in CpG ODNs treated human lung cancer cells.
Our data showed that TLR9 agonist CpG ODNs could induce the expression of HuR in human lung cancer cells. Moreover, overexpression of HuR could reduce the expression of miR-7 in lung cancer cells. Notably, down-regulation of HuR using RNA interference restored miR-7 expression in CpG ODNs treated lung cancer cells, accompanied by enhanced growth and metastatic potential. Finally, CpG ODNs could induce HuR expression through Akt pathway.
Our findings indicated that HuR could act as regulator in regulating TLR9 signaling associated biological effect in human lung cancer cells, which might be helpful for the understanding of the potential role of HuR in tumor biology.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>Binding sites</subject><subject>Gene expression</subject><subject>Lung cancer</subject><subject>MicroRNAs</subject><subject>Primary Research</subject><subject>Proteins</subject><subject>Software</subject><subject>Studies</subject><issn>1475-2867</issn><issn>1475-2867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkUtr3DAUhUVpaR7tursi6CYbJ3pL3hTK0DxgoDCkayHLskfBllzJCu2_r53HkGZVEOjq6NNB9x4APmF0jrESF5hJXhElZIVpVaM34PigvH1RH4GTnO8QwlIJ9B4cEYYQY4Icg3S73dUw-z6YwYceJjcll7Nr4VzGmGAu04OwlKPfVRK63w9nHwOc9ymWfg_LVCXXl8HMqxo7eF120Ae4L6MJcCiLrTXBugStG4b8AbzrzJDdx6f9FPy8_H67ua62P65uNt-2leWcz5WVrcTKKcNrp9q2JcZQYhh2lDWNoEoiSTrSUGYFwYZ1i-i4MHXXWoabhtNT8PXRdyrN6FrrwpzMoKfkR5P-6Gi8_vcm-L3u472mikmmVoOzJ4MUfxWXZz36vLZggosla8x4jXm9zPE_UKYIwTVaXb-8Qu9iScv4V4rSZQkhFurikbIp5pxcd_g3RnqNXq_h6jVcjamu0fLi88t2D_xz1vQvaG2rCQ</recordid><startdate>20130903</startdate><enddate>20130903</enddate><creator>Li, Yong-Ju</creator><creator>Wang, Chun-Hong</creator><creator>Zhou, Ya</creator><creator>Liao, Zheng-Yuan</creator><creator>Zhu, Shun-Fei</creator><creator>Hu, Yan</creator><creator>Chen, Chao</creator><creator>Luo, Jun-Min</creator><creator>Wen, Zhen-Ke</creator><creator>Xu, Lin</creator><general>BioMed Central</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130903</creationdate><title>TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells</title><author>Li, Yong-Ju ; Wang, Chun-Hong ; Zhou, Ya ; Liao, Zheng-Yuan ; Zhu, Shun-Fei ; Hu, Yan ; Chen, Chao ; Luo, Jun-Min ; Wen, Zhen-Ke ; Xu, Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>Binding sites</topic><topic>Gene expression</topic><topic>Lung cancer</topic><topic>MicroRNAs</topic><topic>Primary Research</topic><topic>Proteins</topic><topic>Software</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Yong-Ju</creatorcontrib><creatorcontrib>Wang, Chun-Hong</creatorcontrib><creatorcontrib>Zhou, Ya</creatorcontrib><creatorcontrib>Liao, Zheng-Yuan</creatorcontrib><creatorcontrib>Zhu, Shun-Fei</creatorcontrib><creatorcontrib>Hu, Yan</creatorcontrib><creatorcontrib>Chen, Chao</creatorcontrib><creatorcontrib>Luo, Jun-Min</creatorcontrib><creatorcontrib>Wen, Zhen-Ke</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer cell international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yong-Ju</au><au>Wang, Chun-Hong</au><au>Zhou, Ya</au><au>Liao, Zheng-Yuan</au><au>Zhu, Shun-Fei</au><au>Hu, Yan</au><au>Chen, Chao</au><au>Luo, Jun-Min</au><au>Wen, Zhen-Ke</au><au>Xu, Lin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells</atitle><jtitle>Cancer cell international</jtitle><addtitle>Cancer Cell Int</addtitle><date>2013-09-03</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>90</spage><epage>90</epage><pages>90-90</pages><artnum>90</artnum><issn>1475-2867</issn><eissn>1475-2867</eissn><abstract>Our recent evidence showed that Toll like receptor 9 (TLR9) signaling could enhance the growth and metastatic potential of human lung cancer cells through repressing microRNA-7 (miR-7) expression. Human antigen R (HuR) has been involved in stabilizing multiple mRNAs in cellular biology. However, whether HuR also contributed to the altered expression of miR-7 in TLR9 signaling stimulated human lung cancer cells remains to be elucidated.
The expression of HuR in human lung cancer 95D cells treated with TLR9 agonist CpG Oligonucleotides (ODNs) was detected by Real-time PCR and Western blot assay. To explore the possible role of HuR on miR-7 expression, eukaryotic expression vector encoding HuR was transiently transfected into 95D cells and then the expression of miR-7 was detected by Real-time PCR assay. Moreover, RNA interference, western blot, Real-time PCR, MTT assay, BrdU labeling, invasion assay and scratch assay were employed to examine the disrupt effect of HuR on miR-7 expression in human lung cancer cells treated with CpG ODNs. Finally, inhibitors for PI3K, Akt or Erk respectively, and western blot were performed to explore the possible signaling pathway related to HuR expression in CpG ODNs treated human lung cancer cells.
Our data showed that TLR9 agonist CpG ODNs could induce the expression of HuR in human lung cancer cells. Moreover, overexpression of HuR could reduce the expression of miR-7 in lung cancer cells. Notably, down-regulation of HuR using RNA interference restored miR-7 expression in CpG ODNs treated lung cancer cells, accompanied by enhanced growth and metastatic potential. Finally, CpG ODNs could induce HuR expression through Akt pathway.
Our findings indicated that HuR could act as regulator in regulating TLR9 signaling associated biological effect in human lung cancer cells, which might be helpful for the understanding of the potential role of HuR in tumor biology.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>24004462</pmid><doi>10.1186/1475-2867-13-90</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1475-2867 |
ispartof | Cancer cell international, 2013-09, Vol.13 (1), p.90-90, Article 90 |
issn | 1475-2867 1475-2867 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3847485 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central Free |
subjects | 1-Phosphatidylinositol 3-kinase Binding sites Gene expression Lung cancer MicroRNAs Primary Research Proteins Software Studies |
title | TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A04%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TLR9%20signaling%20repressed%20tumor%20suppressor%20miR-7%20expression%20through%20up-regulation%20of%20HuR%20in%20human%20lung%20cancer%20cells&rft.jtitle=Cancer%20cell%20international&rft.au=Li,%20Yong-Ju&rft.date=2013-09-03&rft.volume=13&rft.issue=1&rft.spage=90&rft.epage=90&rft.pages=90-90&rft.artnum=90&rft.issn=1475-2867&rft.eissn=1475-2867&rft_id=info:doi/10.1186/1475-2867-13-90&rft_dat=%3Cproquest_pubme%3E3075398281%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c555t-c7d718e8a59e8ddd2aa32a41e34bb6387072f2b34c621a4fbb6e56a9fdc41bb53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1433433666&rft_id=info:pmid/24004462&rfr_iscdi=true |